跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IS-217
首页
药物
IS-217
IS-217
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Immunogenic compositions for streptococcus pyogenes
US 7709009 B2
申请人: NOVARTIS VACCINES & DIAGNOSTIC
优先权: 2004
US
8 件公开
Stable phi29 DNA polymerase having high enzyme activity, and encoding gene and application thereof
US 12655399 B2
申请人: BGI SHENZHEN
优先权: 2020
CN
EP
US
WO
5 件公开
Regulator
US 8251981 B2
申请人: OLSEN JAMES M
优先权: 2004
US
4 件公开
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
EP 3919507 A3
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2015
CN
EP
2 件公开
Construction and application of recombinant H5N8 subtype avian influenza virus carrying mapple fluorescence reporter gene
US 12655396 B2
申请人: UNIV SOUTH CHINA AGRICULT
优先权: 2023
CN
US
2 件公开
HYALOPERONOSPORA BRASSICAE RESISTANCE GENE
WO 2025133299 A1
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2023
CN
WO
2 件公开
MONOCLONAL ANTIBODY BINDING TO MICROTUBULE-ASSOCIATED PROTEIN TAU PHOSPHORYLATED AT THREONINE 217 AND USE THEREOF
WO 2025241839 A1
申请人: HKIG IMMUNE TECH HANGZHOU LTD
优先权: 2024
CN
WO
2 件公开
Multiply-substituted protease variants
US 2003073222 A1
申请人: POULOSE AYROOKARAN J
优先权: 2001
US
2 件公开
USE OF THROMBIN MUTANTS TO INHIBIT THE ANTICOAGULATION EFFECT OF THROMBIN INHIBITORS
US 2010158890 A1
申请人: TANAKA KENICHI
优先权: 2007
US
2 件公开
Bleaching compositions comprising multiply-substituted protease variants
US 6831053 B1
申请人: PROCTER & GAMBLE
优先权: 2000
US
第 1 / 6 页
上一页
下一页
药物
反馈